| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a new platelet aggregation inhibitor which can reduce or prevent various symptoms caused by the aggregation of platelets, and particularly, to provide a platelet aggregation inhibitor which can be more easily obtained and whose mass production can be easily achieved as well. <P>SOLUTION: The platelet aggregation inhibitor includes at least one selected from tiglate esters as an active constituent. Further, a flow blood improving agent or an antithrombotic agent using the platelet aggregation inhibitor as an active constituent is provided. <P>COPYRIGHT: (C)2013,JPO&INPIT |
